FERRARI, GIULIANA
 Distribuzione geografica
Continente #
AS - Asia 2.661
EU - Europa 2.642
NA - Nord America 1.547
SA - Sud America 736
AF - Africa 63
OC - Oceania 5
Totale 7.654
Nazione #
RU - Federazione Russa 1.590
US - Stati Uniti d'America 1.477
CN - Cina 982
SG - Singapore 874
BR - Brasile 605
SE - Svezia 426
HK - Hong Kong 312
VN - Vietnam 247
IT - Italia 174
FR - Francia 128
DE - Germania 96
GB - Regno Unito 58
AR - Argentina 55
IN - India 47
BD - Bangladesh 38
FI - Finlandia 33
PL - Polonia 33
CA - Canada 31
JP - Giappone 31
MX - Messico 27
ID - Indonesia 24
AT - Austria 23
EC - Ecuador 21
IE - Irlanda 19
ZA - Sudafrica 19
ES - Italia 18
TR - Turchia 16
NL - Olanda 15
IQ - Iraq 14
CL - Cile 11
CO - Colombia 11
UA - Ucraina 11
PK - Pakistan 10
VE - Venezuela 10
MA - Marocco 9
PE - Perù 9
TN - Tunisia 9
PY - Paraguay 8
KG - Kirghizistan 6
UZ - Uzbekistan 6
CH - Svizzera 5
KE - Kenya 5
MY - Malesia 5
PH - Filippine 5
SA - Arabia Saudita 5
AU - Australia 4
AZ - Azerbaigian 4
DZ - Algeria 4
EG - Egitto 4
ET - Etiopia 4
IL - Israele 4
NP - Nepal 4
AE - Emirati Arabi Uniti 3
BH - Bahrain 3
JO - Giordania 3
KR - Corea 3
PA - Panama 3
QA - Qatar 3
UY - Uruguay 3
AL - Albania 2
BO - Bolivia 2
DO - Repubblica Dominicana 2
HN - Honduras 2
JM - Giamaica 2
LB - Libano 2
LT - Lituania 2
PS - Palestinian Territory 2
PT - Portogallo 2
TH - Thailandia 2
AM - Armenia 1
AO - Angola 1
BE - Belgio 1
BN - Brunei Darussalam 1
BW - Botswana 1
CG - Congo 1
CZ - Repubblica Ceca 1
DM - Dominica 1
GA - Gabon 1
IR - Iran 1
KZ - Kazakistan 1
LY - Libia 1
MD - Moldavia 1
ML - Mali 1
MT - Malta 1
NA - Namibia 1
NI - Nicaragua 1
NO - Norvegia 1
NR - Nauru 1
OM - Oman 1
RO - Romania 1
SC - Seychelles 1
SI - Slovenia 1
SN - Senegal 1
SR - Suriname 1
TT - Trinidad e Tobago 1
TW - Taiwan 1
Totale 7.654
Città #
Moscow 386
Singapore 354
Hong Kong 310
Ashburn 263
Shanghai 197
San Jose 189
Dallas 178
Beijing 139
Hefei 129
Lawrence 112
Princeton 112
Lauterbourg 111
Ho Chi Minh City 95
Milan 65
New York 57
Hanoi 51
Los Angeles 49
São Paulo 40
Boardman 32
Warsaw 26
Helsinki 25
Tokyo 24
Rio de Janeiro 21
Brooklyn 20
Nuremberg 20
Dublin 19
Guangzhou 19
Orem 18
Poplar 16
Belo Horizonte 14
Haiphong 14
Munich 14
Vienna 14
Cesano Boscone 13
Johannesburg 13
Pune 13
Rome 13
Santa Clara 13
Da Nang 12
Frankfurt am Main 12
Ankara 11
Chennai 11
London 10
Salvador 10
San Francisco 10
Shenzhen 10
Stockholm 10
Xi'an 10
Brasília 9
Seattle 9
Tianjin 9
Assago 8
Denver 8
Dhaka 8
Montreal 8
Campinas 7
Council Bluffs 7
Houston 7
Lima 7
Manchester 7
Mexico City 7
Mumbai 7
Nova Iguaçu 7
Phoenix 7
Porto Alegre 7
Quito 7
Thái Bình 7
Toronto 7
Wuxi 7
Amsterdam 6
Bishkek 6
Hangzhou 6
Reston 6
Tashkent 6
Tunis 6
Turku 6
Washington 6
Aracaju 5
Atlanta 5
Boston 5
Caracas 5
Caxias do Sul 5
Goiânia 5
Guarulhos 5
Itajaí 5
Lahore 5
Santo André 5
Thái Nguyên 5
Turin 5
Anápolis 4
Asunción 4
Baghdad 4
Barcelona 4
Barnet 4
Betim 4
Buenos Aires 4
Carapicuíba 4
Changsha 4
Chicago 4
Curitiba 4
Totale 3.613
Nome #
Long-term lineage commitment in haematopoietic stem cell gene therapy 120
Transfer of the HSV-tk gene into donor peripheral blood lymphocytes for in vivo modulation of donor anti-tumor immunity after allogeneic bone marrow transplantation 113
A clinical protocol for transfer of the ADA gene into bone marrow cells and peripheral blood lymphocytes for the treatment of patients affected by ADA deficient SCID 112
A human PBL immunodeficient mouse model for in vivo preclinical studies of human gene therapy. 109
Bone marrow as source of hematopoietic stem cells for human gene therapy of beta thalassemia 107
Bone marrow stromal cells from β-thalassemia patients have impaired hematopoietic supportive capacity 105
NCOA4-mediated ferritinophagy in macrophages is crucial to sustain erythropoiesis in mice 104
Correcting b-thalassemia by combined therapies that restrict iron and modulate erythropoietin activity 104
Transferrin receptor 2 (Tfr2) genetic deletion makes transfusion-independent a murine model of transfusion-dependent β-thalassemia 103
A single approach to targeting transferrin receptor 2 corrects iron and erythropoietic defects in murine models of anemia of inflammation and chronic kidney disease 100
Bone marrow as an alternative site for islet transplantation 100
Removal of innate immune barriers allows efficient transduction of quiescent human hematopoietic stem cells 97
Bone marrow as an alternative site for islet transplantation 91
Targeting the Hematopoietic Stem Cell Niche in β-Thalassemia and Sickle Cell Disease 87
Bone marrow-derived hematopoietic cells undergo myogenic differentiation following a Pax-7 independent pathway 86
Adenine base editor-mediated correction of the common and severe IVS1-110 (G>A) β-thalassemia mutation 84
A Highly conserved SOX6 double binding site mediates SOX6 gene downregulation in erythroid cells 84
An in vivo model of somatic cell gene therapy for human severe combined immunodeficiency 84
Cell-surface marking of CD(34+)-restricted phenotypes of human hematopoietic progenitor cells by retrovirus-mediated gene transfer 83
Bone marrow mesenchymal stem cells express a restricted set of functionally active chemokine receptors capable of promoting migration to pancreatic islets 83
Genetic engineering meets hematopoietic stem cell biology for next-generation gene therapy 82
A retroviral vector containing a muscle-specific enhancer drives gene expression only in differentiated muscle fibers 82
The EHA Research Roadmap: Hematopoietic Stem Cell Gene Therapy 82
Correction of ß-thalassemia major by gene transfer in hematopoietic progenitors of pediatric patients 78
Characterization of Papilloma virus polypeptides from bovine cutaneous fibropapillomas 78
A non-producer interfering HIV-1 provirus can be transduced through a MLV-based retroviral vector: recovery of an anti-HIV mouse/human pseudotype retrovirus 78
Bone marrow-derived stem cells repopulate glomerular and tubular kidney components - Effect of hyperglycemia 76
Gene therapy using haematopoietic stem and progenitor cells 74
Clinical protocol: transfer of the ADA gene into bone marrow cells and peripheral blood lymphocytes for the treatment of patients affected by ADA-deficient SCID 72
An efficient Th2-type memory follows CD8+ lymphocyte-driven and eosinophil-mediated rejection of a spontaneous mouse mammary adenocarcinoma engineered to release IL-4 72
Multiple Integrated Non-clinical Studies Predict the Safety of Lentivirus-Mediated Gene Therapy for β-Thalassemia 71
Aberrant, noninfectious HIV-1 particles are released by chronically infected human T cells transduced with a retroviral vector expressing an interfering HIV-1 variant 70
Terapia genica e malattia ereditaria 68
In vivo and in vitro models for the analysis of retroviral vector mediated expression of human ADA in ADA deficient cells from patients affected by severe combined immunodeficiency. 67
Intrabone hematopoietic stem cell gene therapy for adult and pediatric patients affected by transfusion-dependent ß-thalassemia 67
Reversible immortalisation enables genetic correction of human muscle progenitors and engineering of next-generation human artificial chromosomes for Duchenne muscular dystrophy 65
Safety of retroviral gene marking with a truncated NGF receptor 64
Plerixafor and G-CSF combination mobilizes hematopoietic stem and progenitors cells with a distinct transcriptional profile and a reduced in vivo homing capacity compared to Plerixafor alone 64
Muscle regeneration by bone marrow-derived myogenic progenitors 63
MicroRNA and proliferation control in chronic lymphocytic leukemia: functional relationship between miR-221/222 cluster and p27 63
Pancreatic islets recruit mesenchymal stem cells by release of chemokines 62
Gene-transfer into peripheral-blood lymphocytes for in-vivo immunomodulation of donor antitumor immunity in a patient affected by EBV-induced lymphoma 62
Down-regulation of SPARC/osteonectin/BM-40 expression in methylcholanthrene-induced fibrosarcomas and in Kirsten-MSV transformed fibroblasts 61
Retroviral vector gene-transfer into donor peripheral-blood lymphocytes for in-vitro selection and in-vivo immunomodulation of donor antitumor immunity after allo-BMT 61
Stem cell plasticity: time for a reappraisal? 60
The second transferrin receptor regulates red blood cell production in mice 60
Myogenic conversion of mammalian fibroblasts induced by differentiating muscle cells 60
Retroviral heterogeneity in mouse lymphomas 60
HSV-TK gene transfer into donor lymphocytes for control of allogeneic graft-versus-leukemia 60
Clonal analysis of stably transduced human epidermal stem cells in culture 60
Gene Therapy in Peripheral Blood Lymphocytes and Bone Marrow for ADA- Immunodeficient Patients 59
Transient decrease of serum iron after acute erythropoietin treatment contributes to hepcidin inhibition by ERFE in mice 59
Selective engraftment of genetically modified hematopoietic stem cells by a truncated erythropoietin receptor 58
Transcriptional, epigenetic and retroviral signatures identify regulatory regions involved in hematopoietic lineage commitment 58
Protein kinase a-mediated synapsin I phosphorylation is a central modulator of Ca2+-dependent synaptic activity 58
Transfer of the ADA gene into human ADA-deficient T Lymphocytes reconstitutes specific immune functions 58
Correction of junctional epidermolysis bullosa by transplantation of genetically modified epidermal stem cells 58
Unique molecular and functional features of extramedullary hematopoietic stem and progenitor cell reservoirs in humans 57
Transcriptional targeting of retroviral vectors to the erythroblastic progeny of transduced hematopoietic stem cells 57
Conditioning Regimens in Long-Term Pre-Clinical Studies to Support Development of Ex Vivo Gene Therapy: Review of Nonproliferative and Proliferative Changes 57
Failure to correct murine muscular dystrophy 56
Transcription Factor Binding Sites Are Genetic Determinant of Retroviral Integration in the Human Genome 56
TRANSFER OF THE HSV-TK GENE INTO DONOR PERIPHERAL-BLOOD LYMPHOCYTES FOR IN-VIVO IMMUNOMODULATION OF DONOR ANTITUMOR IMMUNITY AFTER ALLO-BMT 56
Strain polymorphism and tentative mapping of mouse ornithine decarboxylase 55
Transcription factor binding sites as genetic determinants of retroviral integration in the human genome 55
Reversible Immortalization of Human Myogenic Cells by Site-Specific Excision of a Retrovirally Transferred Oncogene 55
Immune reconstitution in ADA-SCID after PBL gene therapy and discontinuation of enzyme replacement 55
Hypomorhic mutation of the TALE gene Prep1 (pKnox1) causes a major reduction of Pbx and Meis proteins and a pleiotropic embryonic phenotype 55
In vivo and in vitro models for analysis of retroviral vector mediated expression of human ADA in ADA deficient cells from patients affected by severe combined immunodeficiency 54
Terapia Genica 54
Gene Therapy Approaches to Hemoglobinopathies 54
Transcript imaging of human T helper cell development using oligonucleotide arrays 53
The homeodomain transcription factor Prep1 (pKnox1) is required for hematopoietic stem and progenitor cell activity 53
Retroviral vectors for human gene therapy 53
Ly-5.185 molecule is associated with thymic maturation of lymphocytes but not with their cytotoxic activity 52
Sox6 enhances erythroid differentiation in human erythroid progenitors 52
Gene therapy for beta thalassemia: preclinical studies on human cells 52
Correction of β-thalassemia by CRISPR/Cas9 editing of the α-globin locus in human hematopoietic stem cells 51
The GATA1-HS2 Enhancer allows persistent and position-independent expression of ß-globin transgene 51
Mesenchymal cells appearing in pancreatic tissue culture are bone marrow-derived stem cells with the capacity to improve transplanted islet function 51
Towards the correction of the genetic defect in corneal keratinocytes from patients with macular corneal dystrophy type II 51
Persistent and Position Independent Transgene Expression in Erythroid Cells Transduced 51
Inhibition of FGF23 is a therapeutic strategy to target hematopoietic stem cell niche defects in β-thalassemia 51
Transcriptional targeting of lentiviral vectors by long terminal repeat enhancer replacement 50
Deletion of a negatively acting sequence in a chimeric GATA-1 enchancer-LTR greatly increases retroviral-mediated erythroid expression 50
Lentiviral vector integration in the human genome induces alternative splicing and generates aberrant transcripts 50
gag, vif, and nef genes contribute to the homologous viral interference induced by a nonproducer human immunodeficiency virus type 1 (HIV-1) variant: identification of novel HIV-1-inhibiting viral protein mutants 50
Granulocyte colony-stimulating factor gene transfer suppresses tumorigenicity of a murine adenocarcinoma in vivo 49
Vector design influences retroviral integration in human hematopoietic cells 49
Retroviral vector-mediated gene transfer into human primary myogenic cells leads to expression into muscle fibers in vivo 49
The influence of vector design on integration site selection by gamma-retroviral and lentiviral vectors 49
Preclinical Assessment of a Gene Therapy Approach to beta-Thalassemia 49
Gene transfer into human primary myogenic cells. 49
T-cell receptor genes in tassel-eared squirrels (Sciurus aberti). I. Genetic polymorhism and divergence in the Abert and Kaibab subspecies 48
Phosphorylation of synapsin I by cAMP-dependent protein kinase controls synaptic vesicle dynamics in developing neurons. 48
Toward epidermal stem cell-mediated ex vivo gene therapy of junctional epidermiolysis bullosa 48
Retroviral vectors for human gene therapy 48
High efficiency myogenic conversion of human fibroblasts by adenoviral vector-mediated MyoD gene transfer. An alternative strategy for ex vivo gene therapy of primary myopathies 47
Mesenchymal Cells Appearing in Pancreatic Tissue Culture Are Bone Marrow-Derived Stem Cells With the Capacity to Improve Transplanted Islet Function 47
Quantitatively different red cell/nucleated cell chimerism in patients with long-term, persistent hematopoietic mixed chimerism after bone marrow transplantation for thalassemia major or sickle cell disease 47
Totale 6.630
Categoria #
all - tutte 53.349
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 53.349


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022112 0 0 0 43 0 2 1 51 4 5 1 5
2022/2023685 253 169 45 5 2 99 25 52 17 9 6 3
2023/2024369 10 20 30 104 15 45 11 5 0 7 19 103
2024/20251.663 218 42 16 62 48 142 295 177 261 171 105 126
2025/20264.910 409 378 351 804 405 134 424 368 1.411 226 0 0
Totale 7.791